U 80493
Alternative Names: U 80493ELatest Information Update: 13 Mar 1995
At a glance
- Originator Pharmacia Corporation
- Class Antiretrovirals
- Mechanism of Action Enzyme inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 13 Mar 1995 No-Development-Reported for HIV infections treatment in USA (Unknown route)